Status:

NOT_YET_RECRUITING

Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

CRC, Colorectal Cancer

Eligibility:

All Genders

50-75 years

Phase:

NA

Brief Summary

In Hong Kong, Colorectal cancer (CRC) ranked second in both cancer incidence and mortality, accounting for 16.7% of all new cancer cases and 14.6% of all cancer-related deaths in 2019. There was a sta...

Detailed Description

It was technically infeasible to conduct fecal test outreach by mailing the test kits in Hong Kong because the government-subsidized colorectal cancer screening program required consultation with a pr...

Eligibility Criteria

Inclusion

  • 50-75 years old
  • asymptomatic and eligible to enroll in a government-subsidized colorectal cancer screening program
  • subjects themselves or their family members living in the same household with access to WhatsApp Messenger
  • able to read Chinese
  • willingness to be followed up by telephone

Exclusion

  • subject without access to WhatsApp Messenger
  • unable to provide informed consent

Key Trial Info

Start Date :

June 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2025

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06192862

Start Date

June 1 2024

End Date

November 30 2025

Last Update

May 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre of Digestive Health, Prince of Wales Hospital

Hong Kong, Hong Kong